Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid‐intolerant asthma
暂无分享,去创建一个
J. Holloway | H-S Park | S.-K. Lee | S-H Kim | J.-H. Choi | C. Park | J. Holloway | H. Shin | C‐S. Park | S.‐K. Lee | H‐S. Park
[1] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[2] K. Ruan. Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway. , 2004, Mini reviews in medicinal chemistry.
[3] Choon-Sik Park,et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. , 2004, The Journal of allergy and clinical immunology.
[4] C. Jenkins,et al. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice , 2004, BMJ : British Medical Journal.
[5] H. Shin,et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase , 2004, Human Genetics.
[6] A. Habib,et al. Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. , 2003, European journal of pharmacology.
[7] H. Shin,et al. Association of thromboxane A2 receptor (TBXA2R) with atopy and asthma. , 2003, The Journal of allergy and clinical immunology.
[8] D. Stevenson,et al. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. , 2003, The Journal of allergy and clinical immunology.
[9] J. Lindgren,et al. Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin‐intolerant asthmatics and healthy volunteers after aspirin treatment , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[10] C. Picado,et al. Aspirin‐intolerant asthma: role of cyclo‐oxygenase enzymes , 2002, Allergy.
[11] P. Montuschi,et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. , 2002, American journal of respiratory and critical care medicine.
[12] T. Shirakawa,et al. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. , 2002, Biochemical and biophysical research communications.
[13] T. Leung,et al. Thromboxane A2 receptor gene polymorphism is associated with the serum concentration of cat‐specific immunoglobulin E as well as the development and severity of asthma in Chinese children , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[14] S. Bavbek,et al. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leucocytes in aspirin‐induced asthmatic patients , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] Yusuke Nakamura,et al. Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association of a T924C polymorphism in the thromboxane A2 receptor gene , 2000, Human Genetics.
[16] D. Stevenson,et al. Aspirin-induced asthma: advances in pathogenesis and management. , 1999, The Journal of allergy and clinical immunology.
[17] M. Hoshino,et al. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma. , 1999, The Journal of allergy and clinical immunology.
[18] S. Fukuyama,et al. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.
[19] S. Holgate,et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. , 1998, The Journal of clinical investigation.
[20] S. Holgate,et al. CYCLO-OXYGENASE. AUTHOR'S REPLY , 1998 .
[21] S. Holgate,et al. Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. , 1997, International archives of allergy and immunology.
[22] H. Mita,et al. Urinary leukotriene E4 and 11‐dehydrothromboxane B2 in patients with aspirin‐sensitive asthma , 1997, Allergy.
[23] P. Devillier,et al. Thromboxane A2 and related prostaglandins in airways , 1997, Fundamental & clinical pharmacology.
[24] R. M. Refini,et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.
[25] N. Hara,et al. BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics. , 1996, Chest.
[26] K. Nishi,et al. Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma. Kanazawa Asthma Research Group. , 1995, Pulmonary pharmacology.
[27] Hae‐Sim Park,et al. Early and late onset asthmatic responses following lysine‐aspirin inhalation in aspirin‐sensitive asthmatic patients , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] A. Ford-hutchinson,et al. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. , 1992, The American review of respiratory disease.
[29] C. Dollery,et al. Thromboxane A2 biosynthesis in acute asthma and after antigen challenge. , 1991, The American review of respiratory disease.
[30] P. O'Byrne,et al. The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness. , 1989, The European respiratory journal.
[31] P. Hedrick,et al. Gametic disequilibrium measures: proceed with caution. , 1987, Genetics.
[32] J. Slapke,et al. Nasal polyposis, bronchial asthma and analgesic intolerance. , 1985, Rhinology.
[33] M. Samter,et al. Concerning the nature of intolerance to aspirin. , 1967, The Journal of allergy.